OOIR: Observatory of International Research

Papers

(The H4-Index of Transplantation is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)

Article	Citations
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation	237
COVID-19 and Solid Organ Transplantation: A Review Article	210
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group	144
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients	122
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant	101
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept	98
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	91
Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center	85
Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients	80
Global Transplantation COVID Report March 2020	77
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity	70
Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India	68
COVID-19 in Lung Transplant Recipients	65
Clinical Implementation of Prolonged Liver Preservation and Monitoring Through Normothermic Machine Perfusion in Liver Transplantation	64
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference	64
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis	63
Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens	63
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients	62
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study	61
New Insights Into the Indications for Intestinal Transplantation: Consensus in the Year 2019	61
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant	61
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	60
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis	58
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration	58
Early Impact of COVID-19 on Solid Organ Transplantation in the United States	56

High-risk Corneal Transplantation: Recent Developments and Future Possibilities	56
COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study	54
Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation	54
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	53
Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors	50
Normothermic Ex Vivo Kidney Perfusion Improves Early DCD Graft Function Compared With Hypothermic Machine Perfusion and Static Cold Storage	50
How to Preserve Liver Grafts From Circulatory Death With Long Warm Ischemia? A Retrospective Italian Cohort Study With Normothermic Regional Perfusion and Hypothermic Oxygenated Perfusion	50
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept	50
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients	50
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection	48
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients	47
Review of Current Machine Perfusion Therapeutics for Organ Preservation	47
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination	47
Impact of Tocilizumab (Anti–IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection	46
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients	45
Histopathologic Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant	45
Does Racial Disparity in Kidney Transplant Waitlisting Persist After Accounting for Social Determinants of Health?	44
Effects of Oxygen During Long-term Hypothermic Machine Perfusion in a Porcine Model of Kidney Donation After Circulatory Death	44
Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Hetero	44
COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management	44
Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience	44